Benzinga | Nov 10, 2021 05:39PM EST

Harpoon Therapeutics Q3 EPS $(0.51) Up From $(0.53) YoY, Sales $4.48M Up From $3.89M YoY

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.51) per share. This is a 3.77 percent increase over losses of $(0.53) per share from the same period last year. The company reported $4.48 million in sales this quarter. This is a 15.18 percent increase over sales of $3.89 million the same period last year.